<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9805456</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20853</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Genet Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Genet. Metab.</journal-id>
<journal-title-group>
<journal-title>Molecular genetics and metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-7192</issn>
<issn pub-type="epub">1096-7206</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30031689</article-id>
<article-id pub-id-type="pmc">6557438</article-id>
<article-id pub-id-type="doi">10.1016/j.ymgme.2018.06.006</article-id>
<article-id pub-id-type="manuscript">NIHMS990000</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>5,10-methenyltetrahydrofolate synthetase deficiency causes a neurometabolic disorder associated with microcephaly, epilepsy, and cerebral hypomyelination</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rodan</surname>
<given-names>Lance H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Wanshu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ducker</surname>
<given-names>Gregory S.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Demirbas</surname>
<given-names>Didem</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laine</surname>
<given-names>Regina</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Edward</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walker</surname>
<given-names>Melissa A.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eichler</surname>
<given-names>Florian</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rabinowitz</surname>
<given-names>Joshua D.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anselm</surname>
<given-names>Irina</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berry</surname>
<given-names>Gerard T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">**</xref>
<xref ref-type="corresp" rid="CR2">***</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="A2"><label>2</label>Department of Neurology, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="A3"><label>3</label>Lewis-Sigler Institute for Integrative Genomics, Department of Chemistry, Princeton University, Princeton, NJ, USA</aff>
<aff id="A4"><label>4</label>Department of Radiology, Boston Children’s Hospital, Boston, MA, USA</aff>
<aff id="A5"><label>5</label>Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<label>**</label>
<p id="P1">These senior authors contributed equally to this work.</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence to: L. Rodan, 300 Longwood Ave, Boston Children’s Hospital, 02115, Boston, MA, USA <email>Lance.Rodan@childrens.harvard.edu</email></corresp>
<corresp id="CR2"><label>***</label>Correspondence to: G. Berry, 3 Blackfan Cir, Boston Children’s Hospital, CL14070, 02115, Boston, MA, USA <email>gerard.berry@childrens.harvard.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P37"><bold>Conflicts of interest:</bold> None</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<volume>125</volume>
<issue>1-2</issue>
<fpage>118</fpage>
<lpage>126</lpage>
<!--elocation-id from pubmed: 10.1016/j.ymgme.2018.06.006-->
<abstract id="ABS1">
<p id="P2">Folate metabolism in the brain is critically important and serves a number of vital roles in nucleotide synthesis, single carbon metabolism/methylation, amino acid metabolism, and mitochondrial translation. Genetic defects in almost every enzyme of folate metabolism have been reported to date, and most have neurological sequelae. We report 2 patients presenting with a neurometabolic disorder associated with biallelic variants in the MTHFS gene, encoding 5,10-methenyltetrahydrofolate synthetase. Both patients presented with microcephaly, short stature, severe global developmental delay, progressive spasticity, epilepsy, and cerebral hypomyelination. Baseline CSF 5-methyltetrahydrolate (5-MTHF) levels were in the low-normal range. The first patient was treated with folinic acid, which resulted in worsening cerebral folate deficiency. Treatment in this patient with a combination of oral L-5-methyltetrahydrofolate and intramuscular methylcobalamin was able to increase CSF 5-MTHF levels, was well tolerated over a 4 month period, and resulted in subjective mild improvements in functioning. Measurement of MTHFS enzyme activity in fibroblasts confirmed reduced activity. The direct substrate of the MTHFS reaction, 5-formyl-THF, was elevated 30-fold in patient fibroblasts compared to control, supporting the hypothesis that the pathophysiology of this disorder is a manifestation of toxicity from this metabolite.</p>
</abstract>
<kwd-group>
<kwd>Folate</kwd>
<kwd>Folinic acid</kwd>
<kwd>Neurometabolism</kwd>
<kwd>Neurodegeneration</kwd>
<kwd>5,10-methenyltetrahydrofolate synthetase</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>